Nine Point Two Capital LLC Ironwood Pharmaceuticals Inc Transaction History
Nine Point Two Capital LLC
- $252 Million
- Q4 2023
A detailed history of Nine Point Two Capital LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Nine Point Two Capital LLC holds 26,046 shares of IRWD stock, worth $96,891. This represents 0.12% of its overall portfolio holdings.
Number of Shares
26,046
Previous 26,046
-0.0%
Holding current value
$96,891
Previous $250,000
18.8%
% of portfolio
0.12%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding IRWD
# of Institutions
238Shares Held
162MCall Options Held
11.2MPut Options Held
9.1K-
Black Rock Inc. New York, NY22.9MShares$85.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA22MShares$82 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$61 Million16.75% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.3MShares$42 Million0.11% of portfolio
-
State Street Corp Boston, MA9.92MShares$36.9 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $570M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...